WELLKEY HOLDINGS LTD has a total of 11 patent applications. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), Australia and Russian Federation. Its main competitors in its focus markets biotechnology and pharmaceuticals are BIOVEX LTD, KIADIS PHARMA INTELLECTUAL PROPERTY BV and CELLECT BIOTHERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Australia | 2 | |
#3 | Russian Federation | 2 | |
#4 | United States | 2 | |
#5 | China | 1 | |
#6 | Malaysia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Lee Eun Kyong | 5 |
#2 | Oh Il Seok | 5 |
#3 | Jin Young Woo | 5 |
#4 | Lee Eun-Kyong | 5 |
#5 | Jang Mi Ok | 5 |
#6 | Lee Young Mi | 4 |
#7 | Jin Young-Woo | 4 |
#8 | Yang Bo Rim | 3 |
#9 | Lee Soo Ran | 3 |
#10 | Kim Il Suk | 3 |
Publication | Filing date | Title |
---|---|---|
RU2662953C1 | Method of obtaining extracts from the genus panax, including wild gins or gins, or cambial meristematic cells relating from the genus panax, or their extracts containing rare ginsenosides in large amount | |
AU2008202078A1 | Stability of secondary metabolite mass production through synchronized plant cell cultures |